Corrigendum to “Development and validation of an ELISA for quantitation of Bovine Viral Diarrhea Virus antigen in the critical stages of vaccine production” (J. Virol. Methods 162/1–2 (2009) (170–178) (S0166093409003590)(10.1016/j.jviromet.2009.07.031));Development and validation of an ELISA for quantitation of Bovine Viral Diarrhea Virus antigen in the critical stages of vaccine production

Journal of Virological Methods

Volumn 162, Issue 1-2, 2009, Pages 170-178

  Pecora, A ^a   Aguirreburualde, M S Perez ^a   Rodriguez, D ^a   Seki, C ^b   Levy, M S ^c   Bochoeyer, D ^c   Dus Santos, M J ^a   Wigdorovitz, A ^a  

^a INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^b Centro de Virologia Animal   (Argentina)

^c Biogenesis Bago   (Argentina)

Author keywords

BVDV; ELISA; Validation

Indexed keywords

ADJUVANT; BIOLOGICAL PRODUCT; BOVINE DIARRHEA VIRUS VACCINE; GLYCOPROTEIN E2; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS VACCINE;

ACCURACY; ANIMAL CELL; ANTIBODY TITER; ANTIGEN PRESENTATION; ARTICLE; BOVINE DIARRHEA VIRUS; CONTROLLED STUDY; COW; DRUG RELEASE; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENITAL SYSTEM DISEASE; IMMUNIZATION; IN VITRO STUDY; LARGE SCALE PRODUCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; REPRODUCIBILITY; VACCINE PRODUCTION; VALIDATION STUDY; VIRAL CONTAMINATION; VIRUS INACTIVATION; VIRUS TITRATION;

BOS; BOVINE VIRAL DIARRHEA VIRUS 1;

EID: 70349746737     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2017.01.022     Document Type: Erratum

References (29)

1. Bahnemann H.G. Inactivation of viruses in serum with binary ethyleneimine J. Clin. Microbio. l 3 2 (1976) 209-210
2. Baker J.C. The clinical manifestations of bovine viral diarrhea infection. Vet. Clin. North Am. Food Anim. Pract. 11 (1995) 425-445
3. Bolin S.R., Ridpath J.F., Black J., Macy M., and Roblin R. Survey of cell lines in the American Type Culture Collection for bovine viral diarrhea virus. J. Virol. Methods 48 (1994) 211-221
4. Breve J.J., Drukarch B., van Strien M., and van Dam A.M. Validated sandwich ELISA for the quantification of tissue transglutaminase in tissue homogenates and cell lysates of multiple species. J. Immunol. Methods 332 (2008) 142-150
5. Claassen I., Maas R., Oei H., Daas A., and Milne C. Validation study to evaluate the reproducibility of a candidate in vitro potency assay of Newcastle disease vaccines and to establish the suitability of a candidate biological reference preparation. Pharmeuropa. Bio. 2004 (2004) 1-15
6. Deregt D., van Rijn P.A., Wiens T.Y., and van den Hurk J. Monoclonal antibodies to the E2 protein of a new genotype (type 2) of bovine viral diarrhea virus define three antigenic domains involved in neutralization. Virus Res. 57 (1998) 171-181
7. Elahi S.M., Shen S.H., Talbot B.G., Massie B., Harpin S., and Elazhary Y. Induction of humoral and cellular immune responses against the nucleocapsid of bovine viral diarrhea virus by an adenovirus vector with an inducible promoter. Virology 261 (1999) 1-7
8. Fournier-Caruana J., Poirier B., Haond G., Jallet C., Fuchs F., Tordo N., and Perrin P. Inactivated rabies vaccine control and release: use of an ELISA method. Biologicals 31 (2003) 9-16
9. Fulton R.W., Saliki J.T., Burge L.J., d'Offay J.M., Bolin S.R., Maes R.K., Baker J.C., and Frey M.L. Neutralizing antibodies to type 1 and 2 bovine viral diarrhea viruses: detection by inhibition of viral cytopathology and infectivity by immunoperoxidase assay. Clin. Diagn. Lab. Immunol. 4 (1997) 380-383
10. Hansen S., Schmidt V., Steffensen M.A., Jensen P.H., Gjerstorff M., Thiel S., and Holmskov U. An enzyme-linked immunosorbent assay (ELISA) for quantification of mouse surfactant protein D (SP-D). J. Immunol. Methods 330 (2008) 75-85
11. Harpin S., Hurley D.J., Mbikay M., Talbot B., and Elazhary Y. Vaccination of cattle with a DNA plasmid encoding the bovine viral diarrhoea virus major glycoprotein E2. J. Gen. Virol. 80 Pt 12 (1999) 3137-3144
12. Jones L.R., Zandomeni R., and Weber E.L. Genetic typing of bovine viral diarrhea virus isolates from Argentina. Vet. Microbiol. 81 (2001) 367-375
13. Kweon C.H., Yoon Y.D., An S.H., and Lee Y.S. Expression of envelope protein (E2) of bovine viral diarrhea virus in insect cells. J. Vet. Med. Sci. 59 (1997) 415-419
14. Liang R., van den Hurk J.V., Landi A., Lawman Z., Deregt D., Townsend H., Babiuk L.A., and van Drunen Littel-van den Hurk S. DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge. J. Gen. Virol. 89 (2008) 453-466
15. Ludemann L.R., and Katz J.B. Enzyme-linked immunosorbent assay assessment of bovine viral diarrhea virus antigen in inactivated vaccines using polyclonal or monoclonal antibodies. Biologicals 22 (1994) 21-27
16. Maas R.A., de Winter M.P., Venema S., Oei H.L., and Claassen I.J. Antigen quantification as in vitro alternative for potency testing of inactivated viral poultry vaccines. Vet. Q. 22 (2000) 223-227
17. Marzocca M.P., Seki C., Giambiagi S.M., Robiolo B., Schauer R., Dus Santos M.J., Scodeller E.A., La Torre J.L., Wigdorovitz A., and Grigera P.R. Truncated E2 of bovine viral diarrhea virus (BVDV) expressed in Drosophila melanogaster cells: a candidate antigen for a BVDV ELISA. J. Virol. Methods 144 (2007) 49-56
18. Munoz D.P., Lager I.A., Mersich S., Zabal O., Ulloa E., Schudel A.A., and Weber E.L. Foetal infections with bovine viral diarrhoea virus in Argentina. Br. Vet. J. 152 (1996) 175-182
19. Pacheco J.M., and Lager I. [Indirect method ELISA for the detection of antibodies against bovine diarrhea virus in bovine serum]. Rev. Argent. Microbiol. 35 (2003) 19-23
20. Paton D.J., Lowings J.P., and Barrett A.D. Epitope mapping of the gp53 envelope protein of bovine viral diarrhea virus. Virology 190 (1992) 763-772
21. Perdrizet J.A., Rebhun W.C., Dubovi E.J., and Donis R.O. Bovine virus diarrhea--clinical syndromes in dairy herds. Cornell Vet. 77 (1987) 46-74
22. Pheasey N., John J., Love C., Coffin R., Ward J.M., Boushaba R., Hoare M., and Levy M.S. A capillary cytometer method to quantitate viable virus particles based on early detection of viral antigens and cellular events within single cells. J. Virol. Methods 137 (2006) 213-218
23. Pinto G.B., Hawkes P., Zabal O., Ulloa E., Lager I.A., Weber E.L., and Schudel A.A. Viral antibodies in bovine fetuses in Argentina. Res. Vet. Sci. 55 (1993) 385-388
24. Pombo M., Berthold I., Gingrich E., Jaramillo M., Leef M., Sirota L., Hsu H., and Arciniega J. Validation of an anti-PA-ELISA for the potency testing of anthrax vaccine in mice. Biologicals 32 (2004) 157-163
25. Rooijakkers E., Groen J., Uittenbogarrd J., van Herwijnen J., and Osterhaus A. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines. Dev. Biol. Stand. 86 (1996) 137-145
26. Rweyemamu M.M., Fernandez A.A., Espinosa A.M., Schudel A.A., Lager I.A., and Mueller S.B. Incidence, epidemiology and control of bovine virus diarrhoea virus in South America. Rev. Sci. Tech. 9 (1990) 207-221
27. Schmitt J., Becher P., Thiel H.J., and Keil G.M. Expression of bovine viral diarrhoea virus glycoprotein E2 by bovine herpesvirus-1 from a synthetic ORF and incorporation of E2 into recombinant virions. J. Gen. Virol. 80 Pt 11 (1999) 2839-2848
28. Vallat B. Principles of validation of diagnostic assays for infectious diseases. Manual of diagnostic tests and vaccines for terrestrial animals, OIE (2008) pp. 34-35 (chapter 1.1.4)
29. Vallat B. Bovine Viral Diarrhoea. Manual of Diagnostic Tests and Vaccines For Terrestrial Animals, OIE (2008) pp. 706-707 (chapter 2.4.8)